ZYMEWORKS INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ZYMEWORKS INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $0.00.
- ZYMEWORKS INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-09-30 was $0.00.
- ZYMEWORKS INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $0.00.
- ZYMEWORKS INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $0.00.
- ZYMEWORKS INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-02 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | |
| 2023-12-31 | $0.00 10-K · filed 2026-03-02 | |
| 2022-12-31 | $0.00 10-K · filed 2025-03-05 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |